Farmakoterapi ADHD pada Pasien Dewasa: Tinjauan Risiko Penyalahgunaan dan Ketergantungan Obat Stimulan

Authors

  • Chalisa Feyruz Eziza Universitas Singaperbangsa Karawang
  • Namira Azzani Universitas Singaperbangsa Karawang
  • Rahmawati Azara Putri Universitas Singaperbangsa Karawang
  • Rozwa Alya Romansyah Universitas Singaperbangsa Karawang
  • Tiara Nuralifa Universitas Singaperbangsa Karawang
  • Mally Ghinan Sholih Universitas Singaperbangsa Karawang
  • Hadi Sudarjat Universitas Singaperbangsa Karawang

DOI:

https://doi.org/10.59024/jikas.v4i3.1895

Keywords:

ADHD, Dependence, Pharmacotherapy, Stimulant Medications, Substance Misuse

Abstract

Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that may persist into adulthood and affect academic, social, and occupational functioning. In adult patients, ADHD is frequently associated with an increased risk of Substance Use Disorder (SUD), raising concerns regarding the potential for misuse and dependence related to stimulant medications used in ADHD therapy. This study aimed to evaluate the effectiveness of pharmacotherapy for adult ADHD and to review the risk of stimulant misuse and dependence based on current scientific evidence. The method employed in this study was a literature review using data obtained from national and international journals indexed in Scopus, PubMed, and Google Scholar published between 2017 and 2026. The findings indicated that stimulant medications, such as methylphenidate and amphetamine, were effective in reducing the core symptoms of ADHD by increasing dopamine and norepinephrine activity in the central nervous system. Most studies reported that the use of stimulant medications at therapeutic doses and under medical supervision was not significantly associated with an increased risk of substance misuse or dependence. The risk of misuse was more commonly observed in cases involving non-medical use and inadequate clinical monitoring. In addition to pharmacological therapy, non-pharmacological approaches such as cognitive behavioral therapy (CBT) also contributed to improving treatment outcomes and patients’ quality of life. Therefore, the use of stimulant medications in adult ADHD patients may be considered relatively safe and effective when administered rationally, individually, and under appropriate medical supervision.

References

Adiputra, I. M., et al. (2021). Faktor risiko attention deficit hyperactivity disorder (ADHD): Tinjauan literatur. Jurnal Kesehatan, 12(2), 85–92.

American Psychiatric Association. (2020). Practice guideline for the treatment of patients with attention-deficit/hyperactivity disorder. Washington, DC: APA Publishing.

Barbuti, M., Maiello, M., Spera, V., Pallucchini, A., Brancati, G. E., Maremmani, A. G. I., Perugi, G., & Maremmani, I. (2023). Challenges of treating ADHD with comorbid substance use disorder: Considerations for the clinician. Journal of Clinical Medicine, 12(9), 3096.

Cândido, R. C. F., et al. (2021). Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews, 2021(11), 1–120.

Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738.

Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014). ADHD stimulant medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878-885.

Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Coghill, D., Cortese, S., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818.

Fitri, A. E., Ramadhani, A., Budiana, D., Nilza, F., Farida, N. R., Sari, M. M., & Widyawati, S. (2025). Attention Deficit Hyperactivity Disorder (ADHD). Jurnal Penelitian Nusantara, 1(2), 5–8.

Hardini, O. S. S., Alpiah, D. N., & Efriandini, L. (2026). Pengaruh latihan fisik terstruktur terhadap perilaku hiperaktivitas pada anak dengan Attention Deficit Hyperactivity Disorder (ADHD) di Yayasan Tri Asih Jakarta. Jurnal Kesehatan Masyarakat Inovatif, 9(2), 86–92.

Kurniawan, A., & Hidayati, E. (2018). Diagnosis dan penatalaksanaan ADHD pada dewasa. Jurnal Kedokteran Indonesia, 6(1), 45–52.

Lestari, D., et al. (2022). Dampak ADHD terhadap performa akademik mahasiswa. Jurnal Psikologi Klinis Indonesia, 10(1), 23–30.

Murniati, R., Sholihatin, I., Khalda, Y. I., & Sulitiawangi. (2024). Diagnose and Treatment of ADHD in Adult Woman: A Literature Review. Jurnal Biologi Tropis, 24(1b), 235-241.

Nasri, F., et al. (2025). Prevalensi dan dampak ADHD pada individu dewasa. Indonesian Medical Journal, 15(1), 10–18.

National Institute for Health and Care Excellence. (2018). Attention deficit hyperactivity disorder: Diagnosis and management (NICE Guideline NG87). London: NICE.

Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A., Dalsgaard, S., van den Brink, W., & Hendriks, V. (2021). Treatment of adolescents with concurrent substance use disorder and attention-deficit/hyperactivity disorder: A systematic review. Journal of Clinical Medicine, 10(17), 3908.

Pratama, R., et al. (2020). Evaluasi penggunaan obat stimulan pada gangguan ADHD. Jurnal Farmasi Klinik Indonesia, 9(2), 101–108.

Putri, A., & Ramadhani, N. (2023). Risiko penyalahgunaan obat stimulan pada ADHD. Jurnal Farmasi Indonesia, 18(1), 55–62.

Song, P., Zha, M., Yang, Q., Zhang, Y., Li, X., & Rudan, I. (2021). The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. Journal of Global Health, 11, 04009.

Widyawati, R., & Sari, D. (2019). Penatalaksanaan ADHD secara farmakologis dan non-farmakologis. Jurnal Kesehatan Mental Indonesia, 8(2), 120–128.

Woon, L. S., Hazli, Z., & Gan, L. L. Y. (2018). Pharmacotherapy for Attention Deficit Hyperactivity Disorder in Adults with Comorbid Stimulant Dependence: A Systematic Review. International Medical Journal Malaysia (IMJM), 17(2), 149-161.

Young, S., Abbasian, C., Al-Attar, Z., Branney, P., Colley, B., Cortese, S., Cubbin, S., Deeley, Q., Gudjonsson, G. H., Hill, P., Hollingdale, J., Jenden, S., Johnson, J., Judge, D., Lewis, A., Mason, P., Mukherjee, R., Nutt, D., Roberts, J., Robinson, F., Woodhouse, E., & Cocallis, K. (2023). Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement. World Journal of Psychiatry, 13(3), 84–112

Downloads

Published

2026-06-26

Issue

Vol. 4 No. 3 (2026): Agustus : JURNAL ILMIAH KESEHATAN MASYARAKAT DAN SOSIAL

Section

Articles

License

Copyright (c) 2026 JURNAL ILMIAH KESEHATAN MASYARAKAT DAN SOSIAL

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.